|Systematic (IUPAC) name|
|(2S,3S,5R)-3-methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide|
|Mol. mass||300.289 g/mol|
| (what is this?)
Tazobactam is a compound that inhibits the action of bacterial β-lactamases. It is combined with the extended spectrum β-lactam antibiotic piperacillin in the drug piperacillin/tazobactam (trade name Tazocin; also Zosyn, Piprataz). It is one of the preferred antibiotic treatments for community-acquired pneumonia (CAP) caused by Pseudomonas aeruginosa. It broadens the spectrum of piperacillin by making it effective against organisms that express β-lactamase and would normally degrade piperacillin.
|This systemic antibacterial-related article is a stub. You can help Wikipedia by expanding it.|